inVentiv Health

About:

inVentiv Health offers clinical and commercial professional services to help biopharmaceutical companies streamline their processes.

Website: http://www.inventivhealth.com

Top Investors: Advent International

Description:

inVentiv Health offers clinical and commercial professional services to help biopharmaceutical companies streamline their processes. As a global, top-tier, clinical, and commercial professional services company, they work with you to evolve and innovate. They've already challenged the status quo by combining a global Clinical Research Organization (CRO) with a global Contract Commercial Organization (CCO) to create a smoother, better process. By combining the best strategic brains in the biopharmaceutical industry with the latest technologies, they've worked to eliminate the roadblocks, territories, fences, hand-offs, and gaps that can hinder the efficiency and speed at which you bring products into the hands of those who need them most. inVentiv Health offers practices, processes, and systems to enable biopharmaceutical clients to successfully navigate an increasingly complex operating environment. They have more than 15,000 healthcare professionals servicing clients in 90 countries. The company has helped to develop or commercialize 80 percent of all new drugs approved by the FDA and 70 percent approved by the EMA over the last five years. So, they have the proven model to help drive your product successfully from lab to life.

Total Funding Amount:

$475M

Estimated Revenue Range:

$1B to $10B

Headquarters Location:

Burlington, Massachusetts, United States

Founded Date:

1996-01-01

Founders:

Number of Employees:

10001+

Last Funding Date:

2016-08-01

IPO Status:

Private

© 2025 bioDAO.ai